BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37973916)

  • 1. Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma.
    Zhang H; Hong Y; Wu T; Ben E; Li S; Hu L; Xie T
    Front Immunol; 2024; 15():1401967. PubMed ID: 38915399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses.
    Wang W; Fan J; Zhang C; Huang Y; Chen Y; Fu S; Wu J
    Microbiol Res; 2024 May; 282():127668. PubMed ID: 38430889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome.
    Derosa L; Iebba V; Silva CAC; Piccinno G; Wu G; Lordello L; Routy B; Zhao N; Thelemaque C; Birebent R; Marmorino F; Fidelle M; Messaoudene M; Thomas AM; Zalcman G; Friard S; Mazieres J; Audigier-Valette C; Sibilot DM; Goldwasser F; Scherpereel A; Pegliasco H; Ghiringhelli F; Bouchard N; Sow C; Darik I; Zoppi S; Ly P; Reni A; Daillère R; Deutsch E; Lee KA; Bolte LA; Björk JR; Weersma RK; Barlesi F; Padilha L; Finzel A; Isaksen ML; Escudier B; Albiges L; Planchard D; André F; Cremolini C; Martinez S; Besse B; Zhao L; Segata N; Wojcik J; Kroemer G; Zitvogel L
    Cell; 2024 Jun; 187(13):3373-3389.e16. PubMed ID: 38906102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma.
    Björk JR; Bolte LA; Maltez Thomas A; Lee KA; Rossi N; Wind TT; Smit LM; Armanini F; Asnicar F; Blanco-Miguez A; Board R; Calbet-Llopart N; Derosa L; Dhomen N; Brooks K; Harland M; Harries M; Lorigan P; Manghi P; Marais R; Newton-Bishop J; Nezi L; Pinto F; Potrony M; Puig S; Serra-Bellver P; Shaw HM; Tamburini S; Valpione S; Waldron L; Zitvogel L; Zolfo M; de Vries EGE; Nathan P; Fehrmann RSN; Spector TD; Bataille V; Segata N; Hospers GAP; Weersma RK
    Nat Med; 2024 Mar; 30(3):785-796. PubMed ID: 38365950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut bacteria affect the tumoral immune milieu: distorting the efficacy of immunotherapy or not?.
    Xiaoyu P; Chao G; Lihua D; Pengyu C
    Gut Microbes; 2020 Jul; 11(4):691-705. PubMed ID: 32216675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. geneshot: gene-level metagenomics identifies genome islands associated with immunotherapy response.
    Minot SS; Barry KC; Kasman C; Golob JL; Willis AD
    Genome Biol; 2021 May; 22(1):135. PubMed ID: 33952321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pan-cancer analysis of the microbiome in metastatic cancer.
    Battaglia TW; Mimpen IL; Traets JJH; van Hoeck A; Zeverijn LJ; Geurts BS; de Wit GF; Noë M; Hofland I; Vos JL; Cornelissen S; Alkemade M; Broeks A; Zuur CL; Cuppen E; Wessels L; van de Haar J; Voest E
    Cell; 2024 Apr; 187(9):2324-2335.e19. PubMed ID: 38599211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal microecological transplantation for a patient with chronic radiation enteritis: A case report.
    Wang L; Li Y; Zhang YJ; Peng LH
    World J Gastroenterol; 2024 May; 30(19):2603-2611. PubMed ID: 38817661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships among gut microbiota, plasma metabolites, and juvenile idiopathic arthritis: a mediation Mendelian randomization study.
    Gao B; Wang Z; Wang K; Lei Y; Zhuang Y; Zhou Z; Chen J
    Front Microbiol; 2024; 15():1363776. PubMed ID: 38605717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference-free Structural Variant Detection in Microbiomes via Long-read Coassembly Graphs.
    Curry KD; Yu FB; Vance SE; Segarra S; Bhaya D; Chikhi R; Rocha EPC; Treangen TJ
    bioRxiv; 2024 Jan; ():. PubMed ID: 38352454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
    Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
    Front Immunol; 2021; 12():669150. PubMed ID: 34267748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiome in modulating immune checkpoint inhibitors.
    Li X; Zhang S; Guo G; Han J; Yu J
    EBioMedicine; 2022 Aug; 82():104163. PubMed ID: 35841869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients.
    Derosa L; Routy B; Fidelle M; Iebba V; Alla L; Pasolli E; Segata N; Desnoyer A; Pietrantonio F; Ferrere G; Fahrner JE; Le Chatellier E; Pons N; Galleron N; Roume H; Duong CPM; Mondragón L; Iribarren K; Bonvalet M; Terrisse S; Rauber C; Goubet AG; Daillère R; Lemaitre F; Reni A; Casu B; Alou MT; Alves Costa Silva C; Raoult D; Fizazi K; Escudier B; Kroemer G; Albiges L; Zitvogel L
    Eur Urol; 2020 Aug; 78(2):195-206. PubMed ID: 32376136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbial structural variation associates with immune checkpoint inhibitor response.
    Liu R; Zou Y; Wang WQ; Chen JH; Zhang L; Feng J; Yin JY; Mao XY; Li Q; Luo ZY; Zhang W; Wang DM
    Nat Commun; 2023 Nov; 14(1):7421. PubMed ID: 37973916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of gut microbial structural variations as determinants of human bile acid metabolism.
    Wang D; Doestzada M; Chen L; Andreu-Sánchez S; van den Munckhof ICL; Augustijn HE; Koehorst M; Ruiz-Moreno AJ; Bloks VW; Riksen NP; Rutten JHW; Joosten LAB; Netea MG; Wijmenga C; Zhernakova A; Kuipers F; Fu J
    Cell Host Microbe; 2021 Dec; 29(12):1802-1814.e5. PubMed ID: 34847370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma.
    Lee KA; Thomas AM; Bolte LA; Björk JR; de Ruijter LK; Armanini F; Asnicar F; Blanco-Miguez A; Board R; Calbet-Llopart N; Derosa L; Dhomen N; Brooks K; Harland M; Harries M; Leeming ER; Lorigan P; Manghi P; Marais R; Newton-Bishop J; Nezi L; Pinto F; Potrony M; Puig S; Serra-Bellver P; Shaw HM; Tamburini S; Valpione S; Vijay A; Waldron L; Zitvogel L; Zolfo M; de Vries EGE; Nathan P; Fehrmann RSN; Bataille V; Hospers GAP; Spector TD; Weersma RK; Segata N
    Nat Med; 2022 Mar; 28(3):535-544. PubMed ID: 35228751
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.